{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T12:03:57Z","timestamp":1781093037953,"version":"3.54.1"},"reference-count":34,"publisher":"SAGE Publications","issue":"4","license":[{"start":{"date-parts":[[2025,7,9]],"date-time":"2025-07-09T00:00:00Z","timestamp":1752019200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Perit Dial Int"],"published-print":{"date-parts":[[2026,7]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Kidney impairment (KI) is a frequent complication of multiple myeloma (MM), with chronic kidney disease (CKD) often necessitating dialysis. Peritoneal dialysis (PD) offers quality-of-life advantages over haemodialysis (HD), yet its use in patients with CKD secondary to MM (CKD-MM) remains understudied. This study investigates the characteristics and outcomes of PD in CKD-MM patients compared to those with other kidney diseases.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This retrospective observational study analysed data from the French Language PD Registry (RDPLF) for patients initiating PD between 2010 and 2020. A 4:1 ratio random sampling was drawn from patients with other kidney diseases to create a control group. Outcomes included death, transfer to HD and kidney transplantation. Cox regression models assessed the impact of CKD-MM on these outcomes, adjusting for baseline variables and treatment era.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Of 12,861 PD patients, 96 (&lt;1%) had CKD-MM. These patients exhibited higher comorbidities and were less likely to be listed for kidney transplantation compared to controls. Among the 96 patients with CKD-MM, 51 (53%) died, 29 (30%) transferred to HD, and 5 (5%) underwent kidney transplant. CKD-MM was not associated with increased risks of death (cause-specific hazard ratio [cs-HR] 1.18, 95% CI 0.83\u20131.67) nor transfer to HD (cs-HR 0.73, 95% CI 0.45\u20131.18). However, CKD-MM patients had a significantly lower chance of transplantation (cs-HR 0.22, 95% CI 0.08\u20130.59).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>PD is a viable modality for CKD-MM, with outcomes comparable to other kidney diseases. Increased attention to PD initiation and transplant access may further optimise care for these patients.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/08968608251357226","type":"journal-article","created":{"date-parts":[[2025,7,9]],"date-time":"2025-07-09T12:28:55Z","timestamp":1752064135000},"page":"386-395","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":0,"title":["Outcomes on peritoneal dialysis in patients with primary kidney disease related to multiple myeloma: A cohort study with data from the French Language Peritoneal Dialysis Registry"],"prefix":"10.1177","volume":"46","author":[{"given":"Laura","family":"Jolec","sequence":"first","affiliation":[{"name":"Centre Universitaire des Maladies R\u00e9nales, CHU de Caen, Caen, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8481-6589","authenticated-orcid":false,"given":"Cl\u00e9mence","family":"Bechade","sequence":"additional","affiliation":[{"name":"Centre Universitaire des Maladies R\u00e9nales, CHU de Caen, Caen, France"},{"name":"U1086 INSERM \u2013 ANTICIPE \u2013 Centre R\u00e9gional de Lutte Contre le Cancer, Fran\u00e7ois Baclesse, Caen, France"},{"name":"Normandie Universit\u00e9, Unicaen, UFR de M\u00e9decine, Caen, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0178-7389","authenticated-orcid":false,"given":"Antoine","family":"Lanot","sequence":"additional","affiliation":[{"name":"Centre Universitaire des Maladies R\u00e9nales, CHU de Caen, Caen, France"},{"name":"U1086 INSERM \u2013 ANTICIPE \u2013 Centre R\u00e9gional de Lutte Contre le Cancer, Fran\u00e7ois Baclesse, Caen, France"},{"name":"Normandie Universit\u00e9, Unicaen, UFR de M\u00e9decine, Caen, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maxence","family":"Ficheux","sequence":"additional","affiliation":[{"name":"Centre Universitaire des Maladies R\u00e9nales, CHU de Caen, Caen, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonia","family":"Guillouet","sequence":"additional","affiliation":[{"name":"U1086 INSERM \u2013 ANTICIPE \u2013 Centre R\u00e9gional de Lutte Contre le Cancer, Fran\u00e7ois Baclesse, Caen, France"},{"name":"Normandie Universit\u00e9, Unicaen, UFR de M\u00e9decine, Caen, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baptiste","family":"Delapierre","sequence":"additional","affiliation":[{"name":"Institut d\u2019h\u00e9matologie, CHU de Caen, Caen, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0945-8056","authenticated-orcid":false,"given":"Thierry","family":"Lobbedez","sequence":"additional","affiliation":[{"name":"Centre Universitaire des Maladies R\u00e9nales, CHU de Caen, Caen, France"},{"name":"U1086 INSERM \u2013 ANTICIPE \u2013 Centre R\u00e9gional de Lutte Contre le Cancer, Fran\u00e7ois Baclesse, Caen, France"},{"name":"Normandie Universit\u00e9, Unicaen, UFR de M\u00e9decine, Caen, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6050-9648","authenticated-orcid":false,"given":"Annabel","family":"Boyer","sequence":"additional","affiliation":[{"name":"Centre Universitaire des Maladies R\u00e9nales, CHU de Caen, Caen, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2025,7,9]]},"reference":[{"key":"e_1_3_4_2_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2022.0003"},{"key":"e_1_3_4_3_2","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djy167"},{"key":"e_1_3_4_4_2","first-page":"3","article-title":"Epidemiology, staging, and management of multiple myeloma","volume":"9","author":"Padala SA","year":"2021","unstructured":"Padala SA, Barsouk A, Barsouk A, et al. Epidemiology, staging, and management of multiple myeloma. Med Sci 2021; 9: 3.","journal-title":"Med Sci"},{"key":"e_1_3_4_5_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2010.30.8791"},{"key":"e_1_3_4_6_2","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfz211"},{"key":"e_1_3_4_7_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0609.2009.01318.x"},{"key":"e_1_3_4_8_2","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2017020212"},{"key":"e_1_3_4_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2019.01.017"},{"key":"e_1_3_4_10_2","doi-asserted-by":"publisher","DOI":"10.1177\/089686089501500301"},{"key":"e_1_3_4_11_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11255-006-9160-z"},{"key":"e_1_3_4_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0272-6386(12)81021-3"},{"key":"e_1_3_4_13_2","first-page":"207","article-title":"Multiple myeloma and light chain-associated nephropathy at end-stage renal disease in the United States: patient characteristics and survival","volume":"56","author":"Abbott KC","year":"2001","unstructured":"Abbott KC, Agodoa LY. Multiple myeloma and light chain-associated nephropathy at end-stage renal disease in the United States: patient characteristics and survival. Clin Nephrol 2001; 56: 207\u2013210.","journal-title":"Clin Nephrol"},{"key":"e_1_3_4_14_2","doi-asserted-by":"publisher","DOI":"10.1111\/nep.12985"},{"key":"e_1_3_4_15_2","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.06290615"},{"key":"e_1_3_4_16_2","doi-asserted-by":"publisher","DOI":"10.1111\/nep.14195"},{"key":"e_1_3_4_17_2","unstructured":"Vakiti A Padala SA Hashmi MF et al. Renal disease in monoclonal gammopathies. In: StatPearls. Treasure Island FL: StatPearls Publishing; 2025."},{"key":"e_1_3_4_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ekir.2022.01.003"},{"key":"e_1_3_4_19_2","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2022.03.010"},{"key":"e_1_3_4_20_2","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gft018"},{"key":"e_1_3_4_21_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41581-021-00405-7"},{"key":"e_1_3_4_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(19)31240-1"},{"key":"e_1_3_4_23_2","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2369-13-31"},{"key":"e_1_3_4_24_2","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.27001"},{"key":"e_1_3_4_25_2","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2014090876"},{"key":"e_1_3_4_26_2","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2023.282905"},{"key":"e_1_3_4_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ekir.2022.02.016"},{"key":"e_1_3_4_28_2","doi-asserted-by":"publisher","DOI":"10.1177\/0896860819896219"},{"key":"e_1_3_4_29_2","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfv132"},{"key":"e_1_3_4_30_2","doi-asserted-by":"publisher","DOI":"10.1053\/ajkd.2000.8286"},{"key":"e_1_3_4_31_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.294.7.813"},{"key":"e_1_3_4_32_2","doi-asserted-by":"publisher","DOI":"10.1177\/0896860820970834"},{"key":"e_1_3_4_33_2","doi-asserted-by":"publisher","DOI":"10.1177\/0896860821989878"},{"key":"e_1_3_4_34_2","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfu359"},{"key":"e_1_3_4_35_2","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.0000000000000280"}],"container-title":["Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/08968608251357226","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/08968608251357226","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/08968608251357226","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T11:20:14Z","timestamp":1781090414000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/08968608251357226"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,9]]},"references-count":34,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["10.1177\/08968608251357226"],"URL":"https:\/\/doi.org\/10.1177\/08968608251357226","relation":{},"ISSN":["0896-8608","1718-4304"],"issn-type":[{"value":"0896-8608","type":"print"},{"value":"1718-4304","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,9]]}}}